Mallory Morales
Director of Finance/CFO chez IMMUNEERING CORPORATION
Fortune : 23 923 $ au 31/03/2024
Profil
Mallory Morales is currently the Treasurer, Chief Financial & Accounting Officer at Immuneering Corp.
Prior to this, Ms. Morales worked as the Director & Assistant Controller at Immunomedics, Inc. from 2018 to 2020.
Before that, Ms. Morales held the position of Director-Finance & Global Brand Controller at L'Oréal SA from 2014 to 2018.
Ms. Morales also worked as a Strategic Finance Business Partner at Gilead Sciences, Inc. from 2020 to 2021.
Ms. Morales obtained an undergraduate degree from the State University of New York at Albany.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
22/03/2024 | 8 278 ( 0,03% ) | 23 923 $ | 31/03/2024 |
Postes actifs de Mallory Morales
Sociétés | Poste | Début |
---|---|---|
IMMUNEERING CORPORATION | Director of Finance/CFO | 10/08/2022 |
Anciens postes connus de Mallory Morales
Sociétés | Poste | Fin |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2021 |
IMMUNOMEDICS, INC. | Director/Board Member | 01/10/2020 |
L'ORÉAL | Director of Finance/CFO | 01/04/2018 |
Formation de Mallory Morales
State University of New York at Albany | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
L'ORÉAL | Consumer Non-Durables |
IMMUNEERING CORPORATION | Health Technology |
Entreprise privées | 1 |
---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |